Palmer Luckey's new firm raises $200 million for engineered war dogs

Warhound, a startup founded by Oculus creator Palmer Luckey, announced it has secured $200 million in new funding. The company stated that its primary goal is to breed dogs with enhanced sensory abilities for military applications. These animals will be trained to detect explosives and provide protection for service members.

The funding round included participation from the venture capital firm Sequoia. Warhound is collaborating with Colossal Biosciences to handle the technical aspects of the project. Colossal Biosciences is a company known for its work in de-extinction and genetic engineering. Their partnership involves using cloning and gene editing techniques to modify the dogs' DNA.

The decision to use genetic modification for military assets marks a shift in how defense technology is developed. Traditionally, military dogs are selected through breeding and rigorous training programs. This new approach aims to biologically enhance specific traits, such as scent detection sensitivity or physical resilience, before the animals enter training.

The company's plan relies on precise genetic interventions. By altering the genetic code, developers hope to create a new class of working dogs that perform better than traditional breeds in high-stress combat environments. The financial backing suggests a long-term investment in this biological technology sector.

This development comes as part of a wider trend in biotechnology applications. While the initial focus is on military utility, the underlying techniques in gene editing and cloning are also being applied in human medicine and conservation efforts. The involvement of Colossal Biosciences links the military project to broader research in synthetic biology.

The startup did not release a detailed timeline for when the first genetically enhanced dogs will be deployed. It also did not specify which genetic traits will be targeted in the initial testing phases. The $200 million capital will fund the research, development, and early breeding programs for the next few years.